Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan Africa

Ilona Carneiro1, Lucy Smith, Amanda Ross

  • 1Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, England. ilona.carneiro@lshtm.ac.uk

Insights

Intermittent preventive treatment in infants (IPTi) effectiveness for malaria control varies by local transmission intensity and seasonality. A new tool helps policymakers assess IPTi

Area of Science:

  • Malaria Control
  • Public Health Policy
  • Mathematical Modeling

Background:

  • Intermittent preventive treatment in infants (IPTi) is a strategy to combat malaria.
  • Assessing the local effectiveness of IPTi is crucial for policy decisions in sub-Saharan Africa.
  • Malaria epidemiology, including transmission intensity and seasonality, significantly influences treatment efficacy.

Purpose of the Study:

  • To develop a decision-support tool for policymakers in sub-Saharan Africa.
  • To evaluate the potential effectiveness of IPTi for local malaria control.

Main Methods:

  • Developed an algorithm combining two predictive approaches.
  • Analyzed age patterns of malaria cases, admissions, and deaths based on transmission intensity and seasonality.
  • Utilized a stochastic mathematical model to predict averted malaria cases under various epidemiological conditions.

Main Results:

  • The proportion of malaria cases targeted by IPTi increases with outcome severity and transmission intensity.
  • The decision-support tool provides context-specific estimates of targeted malaria outcomes (deaths, hospitalizations, clinical cases).
  • The tool quantifies the potential number of malaria cases that could be averted by IPTi implementation.

Conclusions:

  • IPTi effectiveness is contingent upon local malaria transmission intensity and seasonality.
  • Local malaria epidemiology must guide decisions on IPTi implementation.
  • An internet-based decision-support tool is available to predict IPTi effectiveness across diverse epidemiological settings.
Abstract

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...